MediciNova
MNOV
#9531
Rank
NZ$0.12 B
Marketcap
NZ$2.61
Share price
-1.95%
Change (1 day)
-33.10%
Change (1 year)

Revenue for MediciNova (MNOV)

Revenue in 2025 (TTM): NZ$0.22 Million

According to MediciNova's latest financial reports the company's current revenue (TTM ) is NZ$0.23 Million. In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of NZ$1.58 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MediciNova from 2004 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$0.22 M
2024 N/A-100%
2023 NZ$1.58 M
2022 N/A-100%
2021 NZ$5.91 M
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A
2014 N/A-100%
2013 NZ$7.3 M648.79%
2012 NZ$0.97 M
2011 N/A
2010 N/A
2009 N/A
2006 NZ$0.37 M-68.16%
2005 NZ$1.17 M71.21%
2004 NZ$0.68 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eli Lilly
LLY
NZ$102.54 B 44,145,696.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$82.01 B 35,308,543.45%๐Ÿ‡ซ๐Ÿ‡ท France
Alkermes
ALKS
NZ$2.62 B 1,130,174.37%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
NZ$28.95 B 12,463,588.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$97.28 B 41,881,340.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland